SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- CurifyLabs today announced the rollout of its latest innovation in compounding pharmacy technology, the CurifyLabs PharmaPrinter Aurum. The newest ...
Pharmaceutical manufacturing is closely linked to mass production. In order for medicines to be sold cheaply, they often have to be made in huge amounts. But what happens if you need a drug in a ...
APL, one of Sweden’s largest manufacturers of extemporaneous medicines and a leading contract development and manufacturing organization (CDMO), has announced a partnership with CurifyLabs, a Finnish ...
HELSINKI and ATLANTA, Oct. 14, 2025 /PRNewswire/ -- CurifyLabs, a global innovator in 3D printing for compounded medications, today announced the release of its next-generation software platform. The ...
Apotek Produktion & Laboratorier (APL), one of the largest manufacturers of extemporaneous medicines and a leading CDMO in Sweden, has joined forces with CurifyLabs, a Finnish health tech company ...
PharmaPrinter Aurum streamlines pharmacy workflows with enhanced speed, simplified cleaning, and a modern, compact design Founded in 2021, CurifyLabs is transforming how personalized medicines are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results